Clinical Trials Directory

Trials / Completed

CompletedNCT03811210

Using the Norm Range to Predict the Effect of Food Portion Size Reductions on Compensation Over 5 Days

Using the Norm Range to Predict the Effect of Food Portion Size Reductions on Compensation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
39 (actual)
Sponsor
University of Liverpool · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

Reducing food portion size is a potential strategy to reduce energy intake. However it is unclear at what point consumers compensate for reductions in portion size by increasing energy intake from other items. This could result in no overall benefit of reducing food portion sizes. The investigators tested the hypothesis that reductions to the portion size of components of a main meal will only result in significant compensatory eating when the reduced portion size is no longer visually perceived as 'normal'. In a crossover experiment, participants were served different sized portions during lunch and dinner over 5 days: a 'large-normal', a 'small-normal', and a 'smaller than normal' portion. Intake from all other meal components consumed in the laboratory were measured.

Conditions

Interventions

TypeNameDescription
BEHAVIORALportion sizeSmaller than normal portion size - the intervention is the main meal component size perceived as 'smaller than normal' that participants are provided with during lunch and dinner in the laboratory. Small-normal portion size - the intervention is the main meal component size perceived as 'small-normal' that participants are provided with during lunch and dinner in the laboratory. Large-normal portion size - the intervention is the main meal component size perceived as 'large-normal' that participants are provided with during lunch and dinner in the laboratory.

Timeline

Start date
2018-02-06
Primary completion
2018-12-07
Completion
2018-12-10
First posted
2019-01-22
Last updated
2019-01-24

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03811210. Inclusion in this directory is not an endorsement.